Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics
Clinical trial NCT04656119 · UNKNOWN
Trial details
- NCT number
- NCT04656119
- Sponsor
- Beijing Chao Yang Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-03
- Primary completion
- 2022-11-03
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.